# A Study to Evaluate the Safety, Tolerability, Kinetics and Repeatability of 18F-BMS-986327

> **NCT04069143** · PHASE1 · COMPLETED · sponsor: **Bristol-Myers Squibb** · enrollment: 14 (actual)

## Conditions studied

- Healthy Participants
- Idiopathic Pulmonary Fibrosis (IPF)

## Interventions

- **DIAGNOSTIC_TEST:** 18F-BMS-986327

## Key facts

- **NCT ID:** NCT04069143
- **Lead sponsor:** Bristol-Myers Squibb
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-10-01
- **Primary completion:** 2022-07-12
- **Final completion:** 2022-07-12
- **Target enrollment:** 14 (ACTUAL)
- **Last updated:** 2023-03-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04069143

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04069143, "A Study to Evaluate the Safety, Tolerability, Kinetics and Repeatability of 18F-BMS-986327". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04069143. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*